news Consortia of microbes could reduce inflammation and promote colon health, say researchers 16 April 2020 | By Victoria Rees (Drug Target Review) A study has shown that two products of bacterial bile metabolism boost the conversion of precursor T cells into peripheral Tregs, which suppress chronic inflammation in the colon.
news Targeting CD36 with antibody inhibits Treg tumour protection in mice 19 February 2020 | By Victoria Rees (Drug Target Review) Researchers have discovered that an antibody which targets the CD36 protein prevents Tregs from protecting tumours against immunotherapies in mouse models.
news Study uncovers key processes behind MYC cancer gene 26 August 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
news Biomarkers for potential cancer immunotherapy identified 18 June 2019 | By Drug Target Review Researchers have found two biomarkers which play a significant role in the invasion of tumours by T-cells.